Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study
Open Access
- 18 April 2013
- journal article
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 89
Abstract
There is ongoing controversy concerning optimum anticoagulation and buffering in continuous venovenous haemofiltration (CVVH). Regional anticoagulation with trisodium citrate also acting as a buffer in the replacement fluid has several advantages and disadvantages over prefilter citrate administration alone. We analysed a large cohort of patients with acute kidney injury (AKI) treated by the former method and hypothesized that it is safe and efficacious.Keywords
This publication has 30 references indexed in Scilit:
- Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solutionCritical Care, 2012
- Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patientsCritical Care, 2012
- Predilution versus Postdilution Continuous Venovenous Hemofiltration: No Effect on Filter Life and Azotemic Control in Critically Ill Patients on HeparinASAIO Journal, 2011
- Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?Critical Care, 2010
- A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid–base status*Critical Care Medicine, 2009
- Citrate anticoagulation for continuous venovenous hemofiltration*Critical Care Medicine, 2009
- Continuous Venovenous Hemofiltration with or without Predilution Regional Citrate Anticoagulation: A Prospective StudyBlood Purification, 2007
- A NOVEL METHOD FOR REGIONAL CITRATE ANTICOAGULATION IN CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVHF)Renal Failure, 2002
- Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleedingKidney International, 1999
- Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patientsKidney International, 1990